Cytokinetics (CYTK) Surpasses FY14 Estimates Following Recent Astellas Deal; Roth Cap. Affirms at 'Buy'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Cytokinetics (CYTK) Surpasses FY14 Estimates Following Recent Astellas Deal; Roth Cap. Affirms at 'Buy'
CYTOKINETICS (NASDAQ: CYTK) Delayed: 75.35 +2.63 (3.62%)
Previous Close $72.72    52 Week High $13.18 
Open $72.39    52 Week Low $6.00 
Day High $76.81    P/E N/A 
Day Low $72.39    EPS $-1.24 
Volume 1,920,949